Company
United StatesPublic company, NASDAQ: GHGuardant Health, Inc (NASDAQ: GH), Redwood City, CA – FDA Inspections
Inspection records and compliance data for Guardant Health, Inc in Redwood City, California. 4 FDA inspections on record, last inspected January 15, 2026. Publicly traded as NASDAQ: GH.
Company Profile
This profile covers Guardant Health, Inc based in Redwood City, California, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected June 19, 2020. Last inspected January 15, 2026.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 15, 2026 | Not classified | Medical Devices & Rad Health | 1304836 |
| September 27, 2023 | NAI | Medical Devices & Rad Health · Bioresearch Monitoring | 1219097 |
| June 29, 2023 | NAI | Medical Devices & Rad Health · Compliance: Devices | 1210058 |
| June 19, 2020 | NAI | Medical Devices & Rad Health · Bioresearch Monitoring | 1125103 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Guardant Health, Inc
Stock ticker
GH
Exchange
NASDAQ
Share price
$152.97
Market cap
$20.5B
Price as of
November 6, 2026
FEI Number
3012090384
Address
505 Penobscot Dr, Redwood City, California 94063, United States
Country
United States
ID: 58eb8647-068b-4ac6-b839-47218d3aed91